Evidence Map of Pancreatic Surgery-A living systematic review with meta-analyses by the International Study Group of Pancreatic Surgery (ISGPS).


Journal

Surgery
ISSN: 1532-7361
Titre abrégé: Surgery
Pays: United States
ID NLM: 0417347

Informations de publication

Date de publication:
11 2021
Historique:
received: 28 08 2020
revised: 11 04 2021
accepted: 19 04 2021
pubmed: 1 7 2021
medline: 15 12 2021
entrez: 30 6 2021
Statut: ppublish

Résumé

Pancreatic surgery is associated with considerable morbidity and, consequently, offers a large and complex field for research. To prioritize relevant future scientific projects, it is of utmost importance to identify existing evidence and uncover research gaps. Thus, the aim of this project was to create a systematic and living Evidence Map of Pancreatic Surgery. PubMed, the Cochrane Central Register of Controlled Trials, and Web of Science were systematically searched for all randomized controlled trials and systematic reviews on pancreatic surgery. Outcomes from every existing randomized controlled trial were extracted, and trial quality was assessed. Systematic reviews were used to identify an absence of randomized controlled trials. Randomized controlled trials and systematic reviews on identical subjects were grouped according to research topics. A web-based evidence map modeled after a mind map was created to visualize existing evidence. Meta-analyses of specific outcomes of pancreatic surgery were performed for all research topics with more than 3 randomized controlled trials. For partial pancreatoduodenectomy and distal pancreatectomy, pooled benchmarks for outcomes were calculated with a 99% confidence interval. The evidence map undergoes regular updates. Out of 30,860 articles reviewed, 328 randomized controlled trials on 35,600 patients and 332 systematic reviews were included and grouped into 76 research topics. Most randomized controlled trials were from Europe (46%) and most systematic reviews were from Asia (51%). A living meta-analysis of 21 out of 76 research topics (28%) was performed and included in the web-based evidence map. Evidence gaps were identified in 11 out of 76 research topics (14%). The benchmark for mortality was 2% (99% confidence interval: 1%-2%) for partial pancreatoduodenectomy and <1% (99% confidence interval: 0%-1%) for distal pancreatectomy. The benchmark for overall complications was 53% (99%confidence interval: 46%-61%) for partial pancreatoduodenectomy and 59% (99% confidence interval: 44%-80%) for distal pancreatectomy. The International Study Group of Pancreatic Surgery Evidence Map of Pancreatic Surgery, which is freely accessible via www.evidencemap.surgery and as a mobile phone app, provides a regularly updated overview of the available literature displayed in an intuitive fashion. Clinical decision making and evidence-based patient information are supported by the primary data provided, as well as by living meta-analyses. Researchers can use the systematic literature search and processed data for their own projects, and funding bodies can base their research priorities on evidence gaps that the map uncovers.

Sections du résumé

BACKGROUND
Pancreatic surgery is associated with considerable morbidity and, consequently, offers a large and complex field for research. To prioritize relevant future scientific projects, it is of utmost importance to identify existing evidence and uncover research gaps. Thus, the aim of this project was to create a systematic and living Evidence Map of Pancreatic Surgery.
METHODS
PubMed, the Cochrane Central Register of Controlled Trials, and Web of Science were systematically searched for all randomized controlled trials and systematic reviews on pancreatic surgery. Outcomes from every existing randomized controlled trial were extracted, and trial quality was assessed. Systematic reviews were used to identify an absence of randomized controlled trials. Randomized controlled trials and systematic reviews on identical subjects were grouped according to research topics. A web-based evidence map modeled after a mind map was created to visualize existing evidence. Meta-analyses of specific outcomes of pancreatic surgery were performed for all research topics with more than 3 randomized controlled trials. For partial pancreatoduodenectomy and distal pancreatectomy, pooled benchmarks for outcomes were calculated with a 99% confidence interval. The evidence map undergoes regular updates.
RESULTS
Out of 30,860 articles reviewed, 328 randomized controlled trials on 35,600 patients and 332 systematic reviews were included and grouped into 76 research topics. Most randomized controlled trials were from Europe (46%) and most systematic reviews were from Asia (51%). A living meta-analysis of 21 out of 76 research topics (28%) was performed and included in the web-based evidence map. Evidence gaps were identified in 11 out of 76 research topics (14%). The benchmark for mortality was 2% (99% confidence interval: 1%-2%) for partial pancreatoduodenectomy and <1% (99% confidence interval: 0%-1%) for distal pancreatectomy. The benchmark for overall complications was 53% (99%confidence interval: 46%-61%) for partial pancreatoduodenectomy and 59% (99% confidence interval: 44%-80%) for distal pancreatectomy.
CONCLUSION
The International Study Group of Pancreatic Surgery Evidence Map of Pancreatic Surgery, which is freely accessible via www.evidencemap.surgery and as a mobile phone app, provides a regularly updated overview of the available literature displayed in an intuitive fashion. Clinical decision making and evidence-based patient information are supported by the primary data provided, as well as by living meta-analyses. Researchers can use the systematic literature search and processed data for their own projects, and funding bodies can base their research priorities on evidence gaps that the map uncovers.

Identifiants

pubmed: 34187695
pii: S0039-6060(21)00382-2
doi: 10.1016/j.surg.2021.04.023
pii:
doi:

Types de publication

Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1517-1524

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Auteurs

Pascal Probst (P)

Department of General, Visceral, and Transplantation Surgery, University of Heidelberg, Germany; The Study Center of the German Surgical Society (SDGC), University of Heidelberg, Germany. Electronic address: info@evidencemap.surgery.

Felix J Hüttner (FJ)

Department of General, Visceral, and Transplantation Surgery, University of Heidelberg, Germany; The Study Center of the German Surgical Society (SDGC), University of Heidelberg, Germany.

Ömer Meydan (Ö)

The Study Center of the German Surgical Society (SDGC), University of Heidelberg, Germany.

Mohammed Abu Hilal (M)

HPB Department, Southampton General Hospital, Southampton, United Kingdom.

Mustapha Adham (M)

Department of Surgery, Lyon Civil Hospital, France.

Savio G Barreto (SG)

Division of Surgery and Perioperative Medicine, Flinders Medical Centre, Bedford Park, Adelaide, Australia; College of Medicine and Public Health, Flinders University, South Australia, Australia.

Marc G Besselink (MG)

Department of Surgery, Cancer Center Amsterdam, University of Amsterdam, The Netherlands.

Olivier R Busch (OR)

Department of Surgery, Amsterdam UMC, University of Amsterdam, The Netherlands.

Maximillian Bockhorn (M)

Department of General and Visceral Surgery, University Medical Center Oldenburg, Germany.

Marco Del Chiaro (M)

Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, CO.

Kevin Conlon (K)

Hepato-Pancreatico-Biliary Unit, Department of General Surgery, Trinity College Dublin, Tallaght Hospital, Ireland.

Carlos Fernandez-Del Castillo (CF)

Department of Surgery, Massachusetts General Hospital and the Harvard Medical School, Boston, MA.

Helmut Friess (H)

Department of Hepato-Pancreato-Biliary Surgery, Klinikum rechts der Isar, Technische Universität München, Germany.

Giuseppe Kito Fusai (GK)

Institute for Liver and Digestive Health, University College London, United Kingdom.

Luca Gianotti (L)

Pancreatic Surgery Unit, School of Medicine and Surgery, San Gerardo Hospital, University of Milano-Bicocca, Monza, Italy.

Thilo Hackert (T)

Department of General, Visceral, and Transplantation Surgery, University of Heidelberg, Germany.

Christopher Halloran (C)

Department of Molecular and Clinical Cancer Medicine, University of Liverpool, United Kingdom.

Jakob Izbicki (J)

University Medical Center Hamburg-Eppendorf, Germany.

Eva Kalkum (E)

The Study Center of the German Surgical Society (SDGC), University of Heidelberg, Germany.

Dezső Kelemen (D)

Department of Surgery, Clinical Center, Medical School, University of Pécs, Hungary.

Hannes G Kenngott (HG)

Department of General, Visceral, and Transplantation Surgery, University of Heidelberg, Germany.

Rüdiger Kretschmer (R)

The Study Center of the German Surgical Society (SDGC), University of Heidelberg, Germany.

Vincent Landré (V)

The Study Center of the German Surgical Society (SDGC), University of Heidelberg, Germany.

Keith D Lillemoe (KD)

Department of Surgery, Massachusetts General Hospital and the Harvard Medical School, Boston, MA.

Yi Miao (Y)

Pancreas Center, The First Affiliated Hospital of Nanjing Medical University, China.

Giovanni Marchegiani (G)

Department of Surgery, The Pancreas Institute, University and Hospital Trust of Verona, Verona, Italy.

André Mihaljevic (A)

Department of General, Visceral, and Transplantation Surgery, University of Heidelberg, Germany; The Study Center of the German Surgical Society (SDGC), University of Heidelberg, Germany.

Dejan Radenkovic (D)

Department of Surgery, Clinical Center of Serbia and School of Medicine, University of Belgrade, Serbia.

Roberto Salvia (R)

Department of Surgery, The Pancreas Institute, University and Hospital Trust of Verona, Verona, Italy.

Marta Sandini (M)

Department of General, Visceral, and Transplantation Surgery, University of Heidelberg, Germany.

Alejandro Serrablo (A)

Hepatobiliopancreatic Surgery Unit, General and Digestive Surgery Service, Hospital Miguel Servet, Zaragoza, Spain.

Shailesh Shrikhande (S)

Pancreato-Biliary Unit, Tata Memorial Hospital, Mumbai, India.

Parul J Shukla (PJ)

Weill Cornell Medical College & New York Presbyterian Hospital, NY.

Ajith K Siriwardena (AK)

Department of Surgery, Regional Hepato-Pancreato-Biliary Unit, Manchester Royal Infirmary, United Kingdom.

Oliver Strobel (O)

Department of General, Visceral, and Transplantation Surgery, University of Heidelberg, Germany.

Faik G Uzunoglu (FG)

University Medical Center Hamburg-Eppendorf, Germany.

Charles Vollmer (C)

Department of Surgery, Penn Medicine, University of Pennsylvania, Philadelphia, PA.

Jürgen Weitz (J)

Department of General, Thoracic and Vascular Surgery, University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany.

Christopher L Wolfgang (CL)

Department of Surgery, Johns Hopkins Hospital, Baltimore, MD.

Alessandro Zerbi (A)

Pancreatic Surgery, Humanitas Clinical and Research Center-IRCCS, Rozzano (MI), Italy; Humanitas University, Pieve Emanuele (MI), Italy.

Claudio Bassi (C)

Department of Surgery, The Pancreas Institute, University and Hospital Trust of Verona, Verona, Italy.

Christos Dervenis (C)

Department of Surgery, Metropolitan Hospital, Athens, Greece.

John Neoptolemos (J)

Department of General, Visceral, and Transplantation Surgery, University of Heidelberg, Germany.

Markus W Büchler (MW)

Department of General, Visceral, and Transplantation Surgery, University of Heidelberg, Germany.

Markus K Diener (MK)

Department of General, Visceral, and Transplantation Surgery, University of Heidelberg, Germany; The Study Center of the German Surgical Society (SDGC), University of Heidelberg, Germany. Electronic address: https://twitter.com/evidencemap.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH